Ao Liu

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Cardiac Resynchronization Therapy

Acute Heart Failure

Top Venues

Nature communications

Hypertension (Dallas, Tex. : 1979)

This page only lists publications with an associated author ORCID identifier.

Publications

Haobo Weng, Weijuan Zou, Fangyan Tian, Huilin Xie, Ao Liu, Wen Liu, Yu Liu, Nianwei Zhou, Xiaojun Cai, Jianrong Wu, Yuanyi Zheng, Xianhong Shu
Inhalable cardiac targeting peptide modified nanomedicine prevents pressure overload heart failure in male mice. Nature communications 15 (1) (2024)
Haobo Weng, Weijuan Zou, Fangyan Tian, Huilin Xie, Ao Liu, Wen Liu, Yu Liu, Nianwei Zhou, Xiaojun Cai, Jianrong Wu, Yuanyi Zheng, Xianhong Shu
Inhalable cardiac targeting peptide modified nanomedicine prevents pressure overload heart failure in male mice. Nature communications 15 (1) (2024)
Haobo Weng, Weijuan Zou, Fangyan Tian, Huilin Xie, Ao Liu, Wen Liu, Yu Liu, Nianwei Zhou, Xiaojun Cai, Jianrong Wu, Yuanyi Zheng, Xianhong Shu
Inhalable cardiac targeting peptide modified nanomedicine prevents pressure overload heart failure in male mice. Nature communications 15 (1) (2024)
Ao Liu, Huilin Xie, Fangyan Tian, Pei-Yuan Bai, Haobo Weng, Yu Liu, Wen Liu, Lu Tang, Hongmin You, Nianwei Zhou, Xianhong Shu
ESCRT-III Component CHMP4C Attenuates Cardiac Hypertrophy by Targeting the Endo-Lysosomal Degradation of EGFR. Hypertension (Dallas, Tex. : 1979) (2023)